Skip to content
Search

Latest Stories

Pakistan reports around 1,500 fresh COVID-19 cases in a day

PAKISTAN's total number of coronavirus cases reached 35,788 after 1,452 new infections were reported, while the death toll rose to 770 with 33 fresh fatalities, the health ministry said Thursday (14).

The spread of the deadly disease through local transmission showed a dangerous upward trajectory, reports said.


According to the ministry of national health services, Punjab province reported 13,561 cases, Sindh 13,341, Khyber-Pakhtunkhwa 5,252, Balochistan 2,239, Islamabad 822, Gilgit-Baltistan 482 and Pakistan-occupied Kashmir 91 cases.

A total of 9,695 people have fully recovered, shows the latest data.  So far, 330,750 tests have been conducted, including 13,051 in the last 24 hours.

According to a report published by the World Health Organisation Pakistan chapter, the spread of the infection through local transmission showed a dangerous upward trajectory.

Balochistan province showed the highest rate of local transmission at 93 per cent, followed by Sindh (92 per cent), Punjab (85 per cent), Khyber Pakhtunkhwa (84 per cent) and Gilgit-Baltistan (63 per cent), local media reported.

Meanwhile, the Peshawar High Court (PHC) has been closed until May 31 after some of the staff members tested positive for the novel coronavirus.

According to a notification of the PHC Registrar, except the necessary staff, all the offices, branches, bar rooms, advocate general block, consultation room, library and bookshop of the high court will remain closed.

The Pakistan government announced last week that it would begin a phased lifting of the lockdown due to its effect on the economy and the workforce.  As the lockdown was eased, trade activities were resumed with Iran at Taftan after two trade gateways were reopened.

They were closed for two-and-a-half months due to the coronavirus pandemic restrictions.

Ferozsons Laboratories, a local Pakistani company, announced that its subsidiary BF Biosciences Ltd (BFBL) has signed a non-exclusive license agreement with Gilead Sciences Inc for manufacturing and selling remdesivir, an experimental antiviral drug allowed by the US authorities to be used to treat coronavirus patients.

More For You

Climate change could increase child stunting in south Asia by 2050, a study finds

Researchers at the University of California Santa Barbara examined how exposure to extremely climate conditions during pregnancy impacts children's health

iStock - Representative image

Climate change could increase child stunting in south Asia by 2050, a study finds

Highlights

  • Over 3 million additional cases of stunting projected in south Asian children by 2050 due to climate change.
  • Hot-humid conditions four times more harmful than heat alone during pregnancy's third trimester.
  • Early and late pregnancy stages identified as most vulnerable periods for foetal development.

Climate change-driven heat and humidity could lead to more than three million additional cases of stunting among south Asia's children by 2050, according to a new study that highlights the severe health risks facing the world's most densely populated region.

Researchers at the University of California Santa Barbara examined how exposure to extremely hot and humid conditions during pregnancy impacts children's health, focusing on height-for-age measurements, a key indicator of chronic health status in children under five.

Keep ReadingShow less